Inactive Instrument
Tobira Therapeutics Inc Stock
Stocks
US88883P1012
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 55 | - |
Scott Reents
DFI | Director of Finance/CFO | 59 | - |
| Corporate Secretary | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.02% | +1.26% | +41.37% | +105.18% | 69.19B | |
| -0.99% | -4.82% | +31.31% | +74.33% | 62.97B | |
| -1.11% | +2.78% | -14.86% | +375.59% | 27.27B | |
| -4.92% | -3.22% | -3.90% | -17.87% | 24.78B | |
| -1.18% | -1.06% | +29.37% | +14.10% | 25.8B | |
| +0.23% | 0.00% | +23.65% | -16.09% | 20.11B | |
| +6.04% | +7.25% | +233.25% | +383.12% | 18.47B | |
| -1.56% | -2.60% | -8.27% | +514.85% | 14.88B | |
| -2.27% | +1.37% | +53.01% | +160.83% | 14.29B | |
| Average | -0.42% | +0.74% | +42.77% | +177.12% | 30.86B | |
| Weighted average by Cap. | -0.16% | +0.11% | +37.83% | +139.81% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
